Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study
Rationale Mechanistic target of rapamycin inhibitors reduce loss of lung function in lymphangioleiomyomatosis (LAM), although their benefit varies between individuals. We examined lung function response and side effects to rapamycin in a national cohort. Methods Subjects were receiving ra...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
BMJ Publishing Group
2017
|
| Online Access: | https://eprints.nottingham.ac.uk/47947/ |